Kobak, Senol <br/><br/>
Renal cell carcinoma in a patient with rheumatoid arthritis treated with adalimumab.  [electronic resource] 

 -  Current drug safety  Mar 2014 
 - 69-72 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>2212-3911 
<br/><br/><label>Standard No.: </label>10.2174/15748863113086660063  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab<br/>Anti-Inflammatory Agents--adverse effects<br/>Antibodies, Monoclonal, Humanized--adverse effects<br/>Antirheumatic Agents--therapeutic use<br/>Arthritis, Rheumatoid--complications<br/>Biopsy<br/>Carcinoma, Renal Cell--chemically induced<br/>Female<br/>Hematuria--etiology<br/>Humans<br/>Hydroxychloroquine--therapeutic use<br/>Kidney Neoplasms--chemically induced<br/>Middle Aged<br/>Nephrectomy<br/>Positron-Emission Tomography<br/>Prednisolone--therapeutic use<br/>Tomography, X-Ray Computed<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors